Home/Filings/4/0001209191-23-056942
4//SEC Filing

Keyt Bruce 4

Accession 0001209191-23-056942

CIK 0001496323other

Filed

Nov 28, 7:00 PM ET

Accepted

Nov 29, 8:47 PM ET

Size

6.1 KB

Accession

0001209191-23-056942

Insider Transaction Report

Form 4
Period: 2023-11-27
Keyt Bruce
Chief Scientific Officer
Transactions
  • Sale

    Common Stock

    2023-11-27$5.06/sh933$4,720137,125 total
Holdings
  • Common Stock

    (indirect: See footnote)
    1,013
Footnotes (3)
  • [F1]These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
  • [F2]This transaction was executed in multiple trades at prices ranging from $4.96 to $5.33. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
  • [F3]The shares are held directly by the Reporting Person's spouse.

Issuer

IGM Biosciences, Inc.

CIK 0001496323

Entity typeother

Related Parties

1
  • filerCIK 0001787362

Filing Metadata

Form type
4
Filed
Nov 28, 7:00 PM ET
Accepted
Nov 29, 8:47 PM ET
Size
6.1 KB